Embryonic differentiaton factors with anticancer properties: preliminary clinical results in the therapy of advanced tumors

3 March 2017
Embryonic differentiaton factors with anticancer properties: preliminary clinical results in the therapy of advanced tumors

Experiments on animals have shown that regulatory factors can stop or slow down the growth of tumors. These factors are present in embryos of oviparous or in the gravid uterus of mammals, when in the embryo the various tissues differentiate.
These regulators were used in humans to stop or slow down the development of the tumor disease. The therapy consists of the sublingual administration, in drops, of extracts from embryos of zebrafish. The cases treated were seriously ill patients to whom the oncologists had suspended the traditional therapies and patients with significant metastases but still under treatment with chemotherapy, radiotherapy or thermotherapy.
In this study patients in the early stages of disease were not included. In 3 years 20 patients were treated. The results were the following:
1. 80% of the patients showed an increase of the general wellbeing (performance status)
2. The survival curve has reported the interruption of the progression of the disease in a certain number of terminal cases
3. 8% showed a regression of the mass of the tumor.
This study represents an open study and cannot provide definitive final conclusions, except for the non-toxicity of the therapy that has not caused any adverse phenomena. There are other examinations ongoing.

 

Buy the original publication.

 

Leave a Reply

one × two =